North America Active Medical Implantable Devices Market, By Product (Cardiac Resynchronization Therapy Devices (CRT-D), Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Eye Implants, Neurostimulators, Active Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop recorders, Brachytheraphy, Implantable Glucose Monitors, Dropped Foot Implants, Shoulder Implants, Implantable Infusion Pumps, and Implantable Accessories), Surgery Type (Traditional Surgical Methods and Minimally Invasive Surgery), Procedure (Neurovascular, Cardiovascular, Hearing, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Clinics), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Market Analysis and Insights: North America Active Medical Implantable Devices Market
North America active medical implantable devices market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.9% in the forecast period of 2021 to 2028 and is expected to reach USD 12,665.68 million by 2028. Increasing R&D activities in the healthcare industry and increase in healthcare expenditure are the major drivers boosting the growth of the market in the forecast period. Increase in government funding and investment has provided an opportunity for companies to launch more products. However, the high cost and product recall of implantable devices are major challenge for market.
Active implantable medical devices are powered devices that are inserted into a patient’s body by surgical procedure and are intended to remain in the patient’s body after the procedure.
Growing advancements in technology is driving the growth of the North America active medical implantable devices market. The rising investments in new product development activities across major geographies are expected to propel the demand for active medical implantable devices in the coming years. Whereas the cost and harmful effect of treatment is hindering the market growth.
The North America active medical implantable devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Active Medical Implantable Devices Market Scope and Market Size
North America Active medical implantable devices market is segmented on the basis of product, surgery type, procedure, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the North America active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market owing to increase in the demand for implantable devices stoked by their efficient results.
- On the basis of surgery type the North America active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have reasonable cost and expense of the treatment.
- On the basis of procedure, the North America active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
- On the basis of end-users, the North America active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices
North America Active Medical Implantable Devices Market Country Level Analysis
The North America active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, end users.
The countries covered in the active medical implantable devices market report are the U.S., Canada, and Mexico.
Active medical implantable devices segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is leading the growth of the North America active medical implantable devices market and cardiovascular segment is dominating in this country due to increasing prevalence of diseases in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increase in advancement and technology for new product development are boosting the market growth of active medical implantable devices growth
North America active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Active Medical Implantable Devices Market Share Analysis
Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to active medical implantable devices market.
The major companies which are dealing in the North America active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics among others.
Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.
For instance,
- In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care, an Ohio-based long-term care facility which has increased its supply chain in United States.
- In January 2020, Medline Industries, Inc. announced the acquisition of Médi-Sélect, a Quebec City-based medical and dental supplies distributor to join its Medline Canada operations which have increased its distribution and supply chain network
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INDUSTRY INSIGHTS
5 REGULATORY ANALYSIS
5.1 REGULATION IN EUROPE
5.2 REGULATION IN U.S.
5.3 REGULATION IN CANADA
5.4 REGULATION IN CHINA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT
6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS
6.1.3 INCREASING FDA APPROVAL
6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF MEDICAL IMPLANTS
6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS
6.3 OPPORTUNITIES
6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.3.3 INCREASE IN THE GERIATRIC POPULATION
6.3.4 RISING HEALTHCARE INFRASTRUCTURE
6.4 CHALLENGES
6.4.1 INCREASING PRODUCT RECALL
6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK
7 IMPACT OF COVID-19
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)
8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)
8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.4 IMPLANTABLE CARDIAC PACEMAKERS
8.4.1 DUAL CHAMBER PACEMAKERS
8.4.2 BIVENTRICULAR PACEMAKERS
8.4.3 SINGLE CHAMBER PACEMAKERS
8.5 EYE IMPLANTS
8.6 NEUROSTIMULATORS
8.6.1 SPINAL CORD STIMULATORS
8.6.2 DEEP BRAIN STIMULATORS
8.6.3 BLADDER STIMULATORS
8.6.4 GASTRIC NERVE STIMULATORS
8.6.5 SACRAL NERVE STIMULATORS
8.6.6 LIMB FUNCTION STIMULATORS
8.6.7 VAGUS STIMULATORS
8.6.8 OTHERS
8.7 ACTIVE IMPLANTABLE HEARING DEVICES
8.8 VENTRICULAR ASSIST DEVICES
8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS
8.1 BRACHYTHERAPY
8.11 IMPLANTABLE GLUCOSE MONITORS
8.12 DROPPED FOOT IMPLANTS
8.13 SHOULDER IMPLANTS
8.14 IMPLANTABLE INFUSION PUMPS
8.15 IMPLANTABLE ACCESSORIES
8.15.1 LEAD
8.15.2 ELECTRODES
8.15.3 ADAPTORS
8.15.4 OTHERS
9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE
9.1 OVERVIEW
9.2 TRADITIONAL SURGICAL METHODS
9.3 MINIMALLY INVASIVE SURGERY
10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 CARDIOVASCULAR
10.3 NEUROLOGICAL
10.4 HEARING
10.5 OTHERS
11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 AMBULATORY SURGICAL CENTERS
11.4 SPECIALIZED CLINICS
11.5 CLINICS
12 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 BOSTON SCIENTIFIC CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 COCHLEAR LTD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 ABIOMED
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AXONICS, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 BIOTRONIK SE & CO. KG
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 DEMANT A/S
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ECKERT & ZIEGLER.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 GLUSENSE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 MED-EL MEDICAL ELECTRONICS
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 MICROSON
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 NANO RETINA
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 NEUROPACE, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 NEVRO CORP.
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.15.5 RECENT DEVELOPMENTS
14.16 OTICON MEDICAL
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 SECOND SIGHT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SONOVA
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 STIMWAVE LLC
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 45 U.S. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 U.S. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 U.S. IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 U.S. NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 49 U.S. IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 50 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 51 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 52 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 54 CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 55 CANADA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 CANADA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 CANADA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 58 CANADA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 59 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 61 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 63 MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 64 MEXICO TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 65 MEXICO IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 MEXICO NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 67 MEXICO IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 68 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 69 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 70 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SURGERY TYPE LIFELINE CURVE
FIGURE 7 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020
FIGURE 18 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020
FIGURE 22 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 25 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 26 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020
FIGURE 30 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 32 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)
FIGURE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)
FIGURE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)
FIGURE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
